Interestingly Morningstar forecast DPS at 0.16 for FY16 and FY17... 24% yield! this is well above earnings at 0.10 EPS... so not sustainable long term unless earnings lift - but is achievable for a number of years, given the cash sitting on the balance sheet.
If management did choose to distribute excess capital - this would be a good signal as confidence in the long term viability of the TRT market - the Q Axiron net sales figures certainly suggest the downward trend may be bottoming out...
ACR Price at posting:
67.0¢ Sentiment: Buy Disclosure: Held
